2017 EDF/EADV/IPC指南：寻常型银屑病的系统治疗
发布日期：
2017-09-11
英文标题：
European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC
制定者：
出处：
J Eur Acad Dermatol Venereol. 2017 Sep 11.
摘要：
2017年9月，欧洲皮肤病学论坛(EDF)协同欧洲皮肤病与性病学会(EADV)、国际银屑病委员会(IPC)共同更新了寻常型银屑病的系统治疗指南，本文主要更新了应用阿普斯特和苏金单抗治疗寻常型银屑病的相关内容，涉及治疗前，治疗期间和治疗后的相关问题和需要特殊考虑的因素。
展开部分内容仅可在
临床指南app 查看下载
阅读免费指南
发送到邮箱
收藏
分享
评论
提交评论
3056805
2017.12.13
回复
……
/ 没有更多了 /
上传者信息
sharkyu
于2017-09-14上传
编者信息
欧洲皮肤病学论坛
The practice of dermatology has, over the past 30 years, been distinguished by its transition from provision of essentially empirical treatments to a practice in which rational therapies, based on enhanced knowledge of the pathogenesis of disease, are administered. Coincidentally, the boundaries between organ specific specialities such as our own have become blurred. Thus there is now great overlap with numerous other medical disciplines. These include: oncology, immunology / allergology, plastic surgery, oral medicine and, increasingly rheumatology and other disciplines in which management of chronic inflammatory disease plays an important role.
置顶
